title: [Neonatal spasms--a review of symptoms, etiology, therapy and prognosis].
abstract: Seizures in the newborn are a distinctive sign of underlying disease. Different convulsive patterns are described. The most common neurologic syndrome consists of subtle seizures. The most important cause is ischemic encephalopathy. Hypocalcemia is the main metabolic disease. Hypoglycemia seems not to be of special relevance for pathogenesis of newborn seizures. Other episodic symptoms of non-epileptic origin should be considered in the differential diagnosis. It is critical to diagnose the cause and to treat it, since the prognosis depends on the underlying disturbance. Phenobarbital is the anticonvulsive drug of first choice. Duration of treatment is determinated of an preexisting brain damage. Newborns with normal neurological evaluation don't need any longer anticonvulsive treatment after cessation of seizures. The EEG is an important prognostic tool.
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D001238:Asphyxia Neonatorum / Q000150:complications; D001925:Brain Damage, Chronic / Q000175:diagnosis; D003937:Diagnosis, Differential; D004831:Epilepsies, Myoclonic / Q000175:diagnosis; D004828:Epilepsies, Partial / Q000175:diagnosis; D004830:Epilepsy, Tonic-Clonic / Q000175:diagnosis; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis*; D011379:Prognosis; D013036:Spasms, Infantile / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
chemical_list: D000927:Anticonvulsants
vernacular_title: Neugeborenenkrämpfe--Eine Ubersicht über Symptomatik, Atiologie, Therapie und Prognose.